BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33749994)

  • 1. Further expanding the mutational spectrum of brain abnormalities, neurodegeneration, and dysosteosclerosis: A rare disorder with neurologic regression and skeletal features.
    Kındış E; Simsek-Kiper PÖ; Koşukcu C; Taşkıran EZ; Göçmen R; Utine E; Haliloğlu G; Boduroğlu K; Alikaşifoğlu M
    Am J Med Genet A; 2021 Jun; 185(6):1888-1896. PubMed ID: 33749994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.
    Guo L; Bertola DR; Takanohashi A; Saito A; Segawa Y; Yokota T; Ishibashi S; Nishida Y; Yamamoto GL; Franco JFDS; Honjo RS; Kim CA; Musso CM; Timmons M; Pizzino A; Taft RJ; Lajoie B; Knight MA; Fischbeck KH; Singleton AB; Ferreira CR; Wang Z; Yan L; Garbern JY; Simsek-Kiper PO; Ohashi H; Robey PG; Boyde A; Matsumoto N; Miyake N; Spranger J; Schiffmann R; Vanderver A; Nishimura G; Passos-Bueno MRDS; Simons C; Ishikawa K; Ikegawa S
    Am J Hum Genet; 2019 May; 104(5):925-935. PubMed ID: 30982609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From HDLS to BANDDOS: fast-expanding phenotypic spectrum of disorders caused by mutations in CSF1R.
    Guo L; Ikegawa S
    J Hum Genet; 2021 Dec; 66(12):1139-1144. PubMed ID: 34135456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS): new cases, systematic literature review, and associations with CSF1R-ALSP.
    Dulski J; Souza J; Santos ML; Wszolek ZK
    Orphanet J Rare Dis; 2023 Jun; 18(1):160. PubMed ID: 37349768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia.
    Oosterhof N; Chang IJ; Karimiani EG; Kuil LE; Jensen DM; Daza R; Young E; Astle L; van der Linde HC; Shivaram GM; Demmers J; Latimer CS; Keene CD; Loter E; Maroofian R; van Ham TJ; Hevner RF; Bennett JT
    Am J Hum Genet; 2019 May; 104(5):936-947. PubMed ID: 30982608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in CSF1R associated with hereditary diffuse leukoencephalopathy with spheroids.
    Du Q; Wang M; Zhou H
    Neurol Sci; 2022 Jan; 43(1):411-417. PubMed ID: 33948764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling CSF-1 receptor deficiency diseases - how close are we?
    Chitu V; Gökhan Ş; Stanley ER
    FEBS J; 2022 Sep; 289(17):5049-5073. PubMed ID: 34145972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous mutation in
    Daghagh H; Rahbar Kafshboran H; Daneshmandpour Y; Nasiri Aghdam M; Talebian S; Nouri Nojadeh J; Hamzeiy H; Biskup S; Sakhinia E
    Bioimpacts; 2023; 13(3):183-190. PubMed ID: 37431483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family with hereditary diffuse leukoencephalopathy with spheroids caused by a novel c.2442+2T>C mutation in the CSF1R gene.
    Kawakami I; Iseki E; Kasanuki K; Minegishi M; Sato K; Hino H; Shibuya K; Fujisawa K; Higashi S; Akiyama H; Furuta A; Takanashi M; Li Y; Hattori N; Mitsuyama Y; Arai H
    J Neurol Sci; 2016 Aug; 367():349-55. PubMed ID: 27423618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukoencephalopathy with calcifications, developmental brain abnormalities and skeletal dysplasia due to homozygosity for a hypomorphic CSF1R variant: A report of three siblings.
    Beerepoot S; Verbeke JIML; Plantinga M; Nierkens S; Pouwels PJW; Wolf NI; Simons C; van der Knaap MS
    Am J Med Genet A; 2024 Jun; ():e63800. PubMed ID: 38934054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional characterization of novel mutations including frameshift mutation in exon 4 of CSF1R in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
    Miura T; Mezaki N; Konno T; Iwasaki A; Hara N; Miura M; Funayama M; Unai Y; Tashiro Y; Okita K; Kihara T; Ito N; Kanatsuka Y; Jones DT; Hara N; Ishiguro T; Tokutake T; Kasuga K; Nozaki H; Dickson DW; Onodera O; Wszolek ZK; Ikeuchi T
    J Neurol; 2018 Oct; 265(10):2415-2424. PubMed ID: 30136118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the phenotypic spectrum of TNFRSF11A-associated dysosteosclerosis: a case with intracranial extramedullary hematopoiesis.
    Xue JY; Simsek-Kiper PO; Utine GE; Yan L; Wang Z; Taskiran EZ; Karaosmanoglu B; Imren G; Gocmen R; Nishimura G; Matsumoto N; Miyake N; Ikegawa S; Guo L
    J Hum Genet; 2021 Jun; 66(6):607-611. PubMed ID: 33402699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel CSF-1R mutation in a family with hereditary diffuse leukoencephalopathy with axonal spheroids misdiagnosed as hydrocephalus.
    Wang M; Zhang X
    Neurogenetics; 2019 Aug; 20(3):155-160. PubMed ID: 31093799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation.
    Konno T; Yoshida K; Mizuno T; Kawarai T; Tada M; Nozaki H; Ikeda SI; Nishizawa M; Onodera O; Wszolek ZK; Ikeuchi T
    Eur J Neurol; 2017 Jan; 24(1):37-45. PubMed ID: 27680516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of a novel CSF1R mutation causing hereditary diffuse leukoencephalopathy with spheroids.
    Kraya T; Quandt D; Pfirrmann T; Kindermann A; Lampe L; Schroeter ML; Kohlhase J; Stoevesandt D; Hoffmann K; Villavicencio-Lorini P
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00595. PubMed ID: 30729751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids.
    Di Donato I; Stabile C; Bianchi S; Taglia I; Mignarri A; Salvatore S; Giorgio E; Brusco A; Simone I; Dotti MT; Federico A
    J Alzheimers Dis; 2015; 47(2):319-22. PubMed ID: 26401554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF1R mutations identified in three families with autosomal dominantly inherited leukoencephalopathy.
    Mitsui J; Matsukawa T; Ishiura H; Higasa K; Yoshimura J; Saito TL; Ahsan B; Takahashi Y; Goto J; Iwata A; Niimi Y; Riku Y; Goto Y; Mano K; Yoshida M; Morishita S; Tsuji S
    Am J Med Genet B Neuropsychiatr Genet; 2012 Dec; 159B(8):951-7. PubMed ID: 23038421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.
    Sundal C; Fujioka S; Van Gerpen JA; Wider C; Nicholson AM; Baker M; Shuster EA; Aasly J; Spina S; Ghetti B; Roeber S; Garbern J; Tselis A; Swerdlow RH; Miller BB; Borjesson-Hanson A; Uitti RJ; Ross OA; Stoessl AJ; Rademakers R; Josephs KA; Dickson DW; Broderick D; Wszolek ZK
    Parkinsonism Relat Disord; 2013 Oct; 19(10):869-77. PubMed ID: 23787135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
    Lynch DS; Zhang WJ; Lakshmanan R; Kinsella JA; Uzun GA; Karbay M; Tüfekçioglu Z; Hanagasi H; Burke G; Foulds N; Hammans SR; Bhattacharjee A; Wilson H; Adams M; Walker M; Nicoll JA; Chataway J; Fox N; Davagnanam I; Phadke R; Houlden H
    JAMA Neurol; 2016 Dec; 73(12):1433-1439. PubMed ID: 27749956
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Konno T; Kasanuki K; Ikeuchi T; Dickson DW; Wszolek ZK
    Neurology; 2018 Dec; 91(24):1092-1104. PubMed ID: 30429277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.